Table 1.
The Baseline Clinical Characteristics of the 2 Groups (Mean ± SD).
| IFC Group (n = 98) | Control Group (n = 100) | P Value | |
|---|---|---|---|
| Age (year) | 57.12 ± 9.93 | 59.54 ± 10.77 | .087 |
| Sex (M/F) | 52/46 | 45/55 | .257 |
| Physical discomfort | 6.05 ± 0.98 | 5.89 ± 0.86 | .221 |
| Psychosocial discomfort | 9.97 ± 1.15 | 10.22 ± 1.45 | .180 |
| Worries and concerns | 11.69 ± 1.47 | 12.02 ± 1.55 | .130 |
| Satisfaction | 10.46 ± 1.30 | 10.79 ± 1.55 | .106 |
| CCS | 14.16 ± 2.03 | 13.93 ± 1.83 | .397 |
| NRS | 3.29 ± 0.66 | 3.40 ± 0.65 | .221 |
| Daily dosage of oxycodone hydrochloride | 96.02 ± 16.97 | 94.00 ± 13.78 | .359 |
Abbreviations: IFC, interferential current; M, male; F, female; CCS, Cleveland Constipation Scales; NRS, pain Numeric Rating Scales.